Alt-Data Signal Hub

COAG

Hemab Therapeutics Holdings, Inc. · $47.55 (+0.2%) · mkt cap $2.2B

1 hub catalysts across 1 sources · backtest → · ← Ticker Explorer

IPO Lockups (SEC EDGAR)

Signal summary

Converges bullish

Multiple signals point up, none against.

Bullish factors

Insiders net buying (5 vs 0)

Bearish factors

— none —

Best strategy

2-yr backtest · by Sharpe

MACD Crossover has fit COAG best over 2 years (+43.5%, Sharpe 2.33). Historical/in-sample — walk-forward all 19 →

#	Strategy	Return	Sharpe	Beats B&H
1	MACD Crossover	+43.5%	2.33	✓
2	MACD Histogram	+43.5%	2.33	✓
3	RSI Mean-Reversion	+45.0%	2.20	✓

Price — 1 year

daily close

Insider activity

5 open-market buys

Officers & directors trading their own stock (SEC Form 4). Buys are bullish; sells shown for context.

Date	Action	Insider	Shares	Value
2026-06-16	BUY	Ra Capital Management, L.P.	67,669	$1.7M
2026-05-20	BUY	Ra Capital Management, L.P.	4,798	$120K
2026-05-12	BUY	Ra Capital Healthcare Fund,L.P.	6,387	$159K
2026-05-11	BUY	Ra Capital Healthcare Fund,L.P.	51,258	$1.3M
2026-05-06	BUY	Ra Capital Healthcare Fund,L.P.	2,840,429	$71.9M

Analyst ratings

live · 5 changes

Date	Action	Analyst	Rating Change
2026-06-17	Initiated	HC Wainwright & Co.	Buy
2026-05-26	Initiated	Wedbush	Outperform
2026-05-26	Initiated	Jefferies	Buy
2026-05-26	Initiated	Evercore ISI Group	Outperform
2026-05-26	Initiated	Goldman Sachs	Buy

Catalyst timeline

1 hub signals

Date	Source	Event	Entity	Value
2026-10-28	IPO Lockups (SEC EDGAR)	IPO Lockup	Hemab Therapeutics Holdings, Inc. IPO lockup expires 2026-10-28	180	source ↗